Aptevo Therapeutics Inc.
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.72% | 12.27% | -38.59% | -46.88% | -42.91% |
| Total Depreciation and Amortization | -39.22% | -37.98% | -37.92% | -35.13% | -38.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -94.79% | -73.46% | -51.48% | -32.66% | -14.13% |
| Change in Net Operating Assets | 37.98% | -153.32% | -136.96% | -262.28% | -200.57% |
| Cash from Operations | -1.45% | -3.32% | -102.77% | -87.49% | -85.87% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | 128.77% | 98.13% | 64.63% | -7.72% | 32.41% |
| Repurchase of Common Stock | 100.00% | 50.00% | 90.00% | 62.50% | 62.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -- | -- | -- |
| Cash from Financing | 128.89% | 98.25% | 160.00% | 33.20% | 176.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.39% | 46.21% | -42.88% | -227.70% | -44.27% |